Differentiating Scleroderma from other diseases: Difference between revisions

	Scleroderma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Scleroderma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Differentiating Scleroderma from other diseases On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Differentiating Scleroderma from other diseases All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Differentiating Scleroderma from other diseases
CDC on Differentiating Scleroderma from other diseases
Differentiating Scleroderma from other diseases in the news
Blogs on Differentiating Scleroderma from other diseases
Directions to Hospitals Treating Scleroderma
Risk calculators and risk factors for Differentiating Scleroderma from other diseases

Revision as of 13:11, 17 June 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 10: / Line 10: @@
 {{Reflist|2}}
-[[Category:Needs content]]
-[[Category:Autoimmune diseases]]
-[[Category:Diseases involving the fasciae]]
 [[Category:Rheumatology]]
 {{WikiDoc Help Menu}}
 {{WikiDoc Sources}}